3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 26 0 0 0 0 0 0 0999 V2000
-0.0459 -3.0999 0.5507 I 0 0 0 0 0 0 0 0 0 0 0 0
-2.7027 0.5161 0.2805 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5295 -1.1100 -1.3274 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0989 0.9841 -0.5248 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6269 -0.4994 0.1396 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4390 0.8282 -0.2509 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5651 -0.1957 -0.3210 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3538 -1.1331 0.0909 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9251 -0.9290 0.4797 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4886 1.7513 -0.3184 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9749 -0.3329 -0.5277 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9846 -0.0167 0.4168 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7675 1.3024 0.0236 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1293 0.4683 0.1630 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7371 1.4664 1.1254 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3294 1.8469 -0.8313 H 0 0 0 0 0 0 0 0 0 0 0 0
3.1190 -1.9520 0.7891 H 0 0 0 0 0 0 0 0 0 0 0 0
2.3206 2.7784 -0.6244 H 0 0 0 0 0 0 0 0 0 0 0 0
4.9880 -0.3423 0.6780 H 0 0 0 0 0 0 0 0 0 0 0 0
4.6049 1.9942 -0.0183 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.4177 0.7190 -0.8636 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.4799 -0.5412 0.4040 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.8287 1.4564 1.0618 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.4406 1.2388 2.1546 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.3792 2.4781 0.9080 H 0 0 0 0 0 0 0 0 0 0 0 0
1 8 1 0 0 0 0
2 11 1 0 0 0 0
2 14 1 0 0 0 0
3 11 2 0 0 0 0
4 6 1 0 0 0 0
4 7 1 0 0 0 0
4 16 1 0 0 0 0
5 6 1 0 0 0 0
5 8 1 0 0 0 0
5 9 2 0 0 0 0
6 10 2 0 0 0 0
7 8 2 0 0 0 0
7 11 1 0 0 0 0
9 12 1 0 0 0 0
9 17 1 0 0 0 0
10 13 1 0 0 0 0
10 18 1 0 0 0 0
12 13 2 0 0 0 0
12 19 1 0 0 0 0
13 20 1 0 0 0 0
14 15 1 0 0 0 0
14 21 1 0 0 0 0
14 22 1 0 0 0 0
15 23 1 0 0 0 0
15 24 1 0 0 0 0
15 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
ethyl 3-iodo-1H-indole-2-carboxylate
4.2 InChl
InChI=1S/C11H10INO2/c1-2-15-11(14)10-9(12)7-5-3-4-6-8(7)13-10/h3-6,13H,2H2,1H3
4.3 InChlKey
BZVJUWYDEMOJMH-UHFFFAOYSA-N
4.4 Canonical SMILES
CCOC(=O)C1=C(C2=CC=CC=C2N1)I
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病